FilingFirehose · free AI preview
TENAX THERAPEUTICS, INC.
TENX · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Tenax Therapeutics (TENX) filed a red-flag 8-K on April 22, 2026 disclosing an officer departure, a material corporate event warranting closer examination. With no cyber incidents detected in the past 90 days, the immediate operational risk profile appears contained, though officer transitions often signal broader strategic or financial pressures. Our full $49 Report provides comprehensive 12-month filing analysis, quantified dilution risk scoring, detailed 8-K context, complete financing history, and AI-detected risk signals across all SEC filings. The full $49 Report adds institutional-grade risk assessment beyond the headline event.
Want the full 5-section $49 Report on TENX?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.